NIAID conducts and supports basic research to better understand viruses, bacteria, and other infectious agents that cause diseases of public health concern. This research provides the foundation for developing medical products and strategies to diagnose, treat, and prevent a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism.
Ciprofloxacin Licensed to Treat Pneumonic Plague —May 20, 2015
Experimental Ebola Vaccine Safe, Prompts Immune Response—April 1, 2015
Sequential Immunization with VSV-Based Lassa and Ebola Vaccines Does Not Diminish Protection in Monkeys, NIAID Study Finds—Nov. 14, 2014
NIH to Launch Human Safety Study of Ebola Vaccine Candidate—Aug. 28, 2014
All Biodefense and Emerging Infectious Diseases News and Events
Last Updated May 28, 2015